This stock will take a few years to mature. Managment team is solid and visionary - a nice combination for those willing to wait through the costs of acquisitions. ASCs are gaining in popularity, especially with outpatient procedures.
In case anyone hasn't noticed. There was a 3:1 reverse split on this stock, and the growth shown in the charts on fool.com are the result of a glitch. be careful out there people.